US FDA centers to deploy AI internally, following experimental run

FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

(Reuters) - The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally immediately, with full integration on June 30, following the completion of a new generative AI pilot for scientific reviewers.

WHY IT'S IMPORTANT